{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000034","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.413593+00:00","generated_at":"2026-06-20T14:41:13.335267+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioSig Technologies raises ~$1.25M through sale of common stock and warrants","bullets":["Sold 2,178,316 shares at $0.57608 per share, raising $1,254,884 in aggregate.","Issued warrants to purchase up to 1,089,158 shares at $0.51358; exercisable after 6 months, expire in 5.5 years.","Offering made to institutional and accredited investors under Section 4(a)(2) and Regulation D.","No material change to business operations or strategy disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000034","json":"https://secwatch.observer/filing/0001185185-23-000034.json","markdown":"https://secwatch.observer/filing/0001185185-23-000034.md","text":"https://secwatch.observer/filing/0001185185-23-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000034/0001185185-23-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000034/biosig20230112_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T14:41:13.335267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"910a1a8b088671130b666e8308b7510ce1996455","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,254,884.28 (effective 2023-01-10).","evidence_excerpt":"On January 10, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,178,316 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.57608 per share, and warrants (the “Warrants”) to purchase up to 1,089,158 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.51358 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,254,884.28.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000034/0001185185-23-000034-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional and accredited investors"},{"label":"Value","value":"$1,254,884.28"},{"label":"Effective","value":"2023-01-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}